Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-28

FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

The FDA approved Strides Pharma Science Limited's original application for a generic fixed-dose combination of amlodipine and valsartan for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

ORIG AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)